A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
Clinical trial NCT03092323 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03092323
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-19
- Primary completion
- 2025-09-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.